We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 3.39% | 1.525 | 1.50 | 1.55 | 1.525 | 1.425 | 1.48 | 4,566,400 | 16:18:36 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.29 | 11.79M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/2/2020 23:19 | Nobby, Fancy a bet here or in metro ? Metro my bet is > 200p on 26th Here IMM > 30p by December 2020 Fancy a bet ? For IMM I am happy to give you higher odds Please let me know and we can facilitate bet | marie1980 | |
15/2/2020 23:11 | Thank you bes. Meanwhile here for Nobby from IMM board. You are a failure and an idiot. You called this wrong before. Thankfully I didn't listen and was in for a decent rise. Definitely won't be listening to you again. It's a shame you're so bitter and twisted about being proved wrong and missing out you have to stick around like a bad smell polluting this BB. | marie1980 | |
15/2/2020 20:02 | Marie1980 I’m invested have been for some time and am also in DNL if they get EMA approval for chronocourt which looks likely FDA is less sure and at least 12/18 months away. While the long term potential of accrefur Feracru is greater I would expect DNl to grow at a faster rate over the next 2 years and from current valuation DNLwhile carriers greater risk in the short term is extremely attractively valued. Time will tell as always and while I’m not a fan of ramping or deramping for that matter Just thought I would voice my opinion on DNL | best1467 | |
13/2/2020 20:25 | Ny boy on DNL board few days back wrote this Looks ready to start a momentum move, could do with some decent news to get to 89p though, maybe a target price for Q4 Then couple of days back Nice update, gap to 35p coming up, as first test Ny Boy, you are just tarnishing you’re reputation by unnecessary ramping. Atlesst be sensible with your ramping. And you kept saying DYOR. Love, why can’t you just add “useful” and “researched And don’t compare DNL with Shield. Shield product will generate far more millions than DNL. So stop ramping and be sensible with your post it you want some other member to notice you. | marie1980 | |
13/2/2020 16:27 | ny_boy - wrong board again! Please stop pumping and ramping - go on ... try for day at least? (btw - if you keep finishing your posts with 'do your own research' then there is no need for you to post is there... unless you are pumping.. ;-) | growthinvestor2001 | |
13/2/2020 10:04 | Anyone following (DNL), they just got a date from FDA for decision on drug application a bit like where Shield were in March of last year...around 40/50p. I am looking for a x3 + if they get FDA approval at end of Sept...dyor as usual. | ny boy | |
12/2/2020 17:43 | FWIW Medicaid in Virginia has listed Accrufer after a 12 week trial of an oral iron. I believe this is a normal timeline for Medicaid listing. hxxps://www.virginia | crankyman | |
12/2/2020 14:13 | Usual drivel from ny_boy: 1. Telling us where hes on holiday (who cares or who can prove it?) 2. Generic post related to the board which he has posted countless times before re US deal. General pump / ramp of other stocks he holds. Very boring isn't it - please stop ramping/pumping ny_boy - bet you can't. | growthinvestor2001 | |
12/2/2020 14:03 | Lol, I hold both, happy to hold, no reason to sell as I bought very cheap, still on Asia relaxing, every day blue sky and warmth, I don’t miss Blighty during the long short and gloomy winter days. Made a load on NMC, keep a core for potential bid/s Holding FIN,PPS, ITX and a load of others, which are starting to do well. Happy days, just awaiting US commercialisation deal here. Dyor as usual. | ny boy | |
12/2/2020 12:05 | Nobby - IMM flying. up 22% since i quit Shield. | marie1980 | |
11/2/2020 16:26 | All comes down to how much you can afford lose...sadly my pockets arnt that deep | kop202 | |
10/2/2020 12:37 | I like to form an opinion slightly earlier to catch the large gains not always but you can get it wrong several times and still be making large returns as Long as you get right occasionally and stay in | best1467 | |
09/2/2020 17:57 | My experience of AIM is that it is best to hold back and wait till the chances of failure have diminished.The MM's have a habit of causing an overhang in the share price at this time (when the development is at an end and revenue streams are imminient) giving the investor who has done his/ her research plenty of time to enter the market.People always have a FOMO with AIM companys in the development stageMy experience is that is not the case... | kop202 | |
08/2/2020 22:28 | While IMM is very high risk Marie could well get a better percentage gain over the next two years but he could also lose All £67k which will not happen here. I commented over on the IMM board a month or so that if the FDA agree a P3 pathway then from current levels prior to read out a decent return could be made.But I don’t see much action in the next 12 months and not sure what is investment strategy is but it seems a little all in approach but good luck | best1467 | |
08/2/2020 21:17 | >> Marie I say it as it is! I am positive on many stocks, particularly TLY and OPTI. However, Lupuzor will not work if used at the same dose as before. Simples! Yes I know that doesn't matter to you but IMM management are poor so be very careful. | nobbygnome | |
08/2/2020 20:19 | Sorry did I miss your summary nobby? Could you re post ? Thanks | 2theduke | |
08/2/2020 11:06 | I like you Nobby. You’re expert of deramping. Anyway, to answer your question. Atleast I take a solace that I’m not investing in a binary outcome. I’m investing in IMM because 1. This is dirt cheap 2. Avion’s track record of turn around the things and considering they put £25m shoes their confidence. 3. Speculation and anticipation nearer to P3 itself will push to around 40-50p level if not 180p like last time. 4. I’m confident FDA will approve P3 with different dosage criteria compared to last time. One last thing, I’m ready to lose my entire pot of £67K. That’s fine with me. I’m young and I will earn down the line. But I appreciate your concern. We want get many sympathetic board members like you so much appreciated. I know once P3 trial approved by FDA with certain protocol, then you will deramp again with “abs signal” in USA patient. Then you will deramp again that last time IMM failed so no way they will succeed again. But honestly, I like you. I wish everyone be as sympathetic and as genuine like you. All the best. Sorry stx members. Consider this my last last message and Nobby now feel free to pop over IMM board rather than spam this shield board with other shares. Cheers and have a lovely weekend. | marie1980 | |
08/2/2020 08:30 | Wow £65k in IMM. I am not sure you realise the risk you are taking. What will the price be if Avion pull out because of issues with the FDA? From my knowledge of the drug and how the FDA works, that is a perfectly possible scenario. There are no guarantees they will agree to the phase III trial plan. Remember that the anti-DNA ab 'signal' was not present in US patients. IMM can't have it both ways. If that data is significant in Europe, then you have to say it is not significant in the US. I am not saying it will happen but it is possible. | nobbygnome | |
07/2/2020 15:36 | Agree KoP... and consider this is my last message in Sheild. I've had good fun and return in STX. Adios!! Take care and I'm pretty sure this will easily go past to £2.5 once US deal announced. | marie1980 | |
07/2/2020 14:35 | Poor use of capital imo...IMM is going nowhere fast.. | kop202 | |
07/2/2020 14:13 | I don't know Kop202, But with that I've now sold all my £16,000 and invested fully in IMM. My total investment in IMM is now £65,000 Happy to wait for 2-4 years. | marie1980 | |
07/2/2020 14:08 | Marie...your a bit of an optomist to say the least......whats changed since the share price collapse in IMM? | kop202 | |
07/2/2020 13:49 | 110% agree with you Nobby but the profit I know I'll get in IMM over next 2 years will be far more than here in Shield. But yes, your point is perfectly valid. It's just I see move value there rather than here. | marie1980 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions